CAI
Caris Life Sciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$33.22
+1.13%Forward multiples
Based on analyst estimates
- P/E forward
- 107.82x
- P/E 2026E
- 266.41x
- P/E 2027E
- 91.44x
- P/E 2028E
- 62.39x
- P/S forward
- 8.04x
Trailing multiples
Trailing twelve months
- P/E TTM
- 89.33x
- PEG TTM
- —
- Price / book
- 15.86x
- Price / sales
- 9.49x
- Price / cash flow
- 46.60x
Enterprise value
- Enterprise value
- $9.0B
- EV / sales
- 9.14x
- EV / EBITDA
- 52.39x
- EV / EBIT
- 59.03x
- Market cap
- $9.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026